Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization

Tobacco Use Cessation Clinical Trial

Official title:

Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02099097
• Other study ID #: 14-062
• Status: Completed
• Phase: N/A
• Start date: March 24, 2014
• Est. completion date: December 24, 2020

Study information

• Verified date: December 2020
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to develop and test a web-based game called Quit It that is designed to help smokers who have quit smoking cope with any smoking urges they may have. The purpose of the game is to help people quit and stop people from smoking again.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 24, 2020
• Est. primary completion date: December 24, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age = 18 years old

• English-speaking

• Cancer (solid tumor) diagnosis or mass suspicious of cancer within past six months as per clinical judgment

• Cancer treatment expected plan to include hospitalization for surgical treatment for at least 2 days at MSKCC as per the patients clinical team

• Referred to MSK's Tobacco Cessation Program

• Patient-reported cigarette use within the past 30 days

• Have sufficient sensory acuity (i.e., auditory, visual) and manual dexterity to use a computer game as per judgment of clinician or consenting professional

• Can be reached by telephone

Exclusion Criteria:

• Distant metastatic disease at the time of enrollment

• Major psychiatric illness or cognitive impairment that in the judgment of the investigator would preclude study participation

• Any patients who are unable to comply with the study procedures as determined by the study investigators

Related Conditions & MeSH terms

• Tobacco Use Cessation

Intervention

Other:
• web-based video game (Quit IT)

Behavioral:
• Questionnaires
In order to maximize survey the response rate, patients will be mailed a reminder letter approximately two weeks before the 1 month follow up surveys are due. If the survey is not returned, patients will be sent additional reminders on the survey due date as well as two weeks past the due date.

Other:
• Salvia sample
The investigators will inform patients prior to obtaining their self-reports that a saliva test or expired CO sample for those using NRT or electronic cigarettes will be performed to examine recent tobacco exposure.

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (3)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	Muzzy Lane Software, New York University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	quitting smoking self-efficacy	as measured by the Confidence Questionnaire to assess changes in confidence in being able to resist urges to smoke across everyday situations.	1 year
Secondary	efficacy of the game	on smoking abstinence and relapse prevention. We will examine time to smoking relapse following hospitalization, measured as part of the follow-up Smoking Status 1 month following enrollment. We will also biochemically verify 7-day point prevalence smoking abstinence at the 1 month follow-up assessment.	1 year

External Links

•   Memorial Sloan Kettering Cancer Center